Dura Mater Nick Cut or Tear
2 clinical trials · Condition
◉ Watch Dura Mater Nick Cut or Tear
| Record | Firm | Date |
|---|---|---|
| Hemopatch Performance Evaluation: A Prospective Observational Registry (NCT03392662) | Baxter Healthcare Corporation | 2017-11-29 |
| Duragen® Secure Post Marketing Clinical Follow-up (PMCF) (NCT02225080) | Integra LifeSciences Corporation | 2014-10-01 |
Track Dura Mater Nick Cut or Tear automatically
Every clearance here is in the API, with alerts when new ones post.